Cantor Fitzgerald Starts Cartesian Therapeutics (RNAC) at Neutral
Tweet
Share
E-mailGet Alerts RNAC Hot Sheet
Price: $8.72 +0.46%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 2
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 2
Join SI Premium – FREE
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Cartesian Therapeutics (NASDAQ: RNAC) with a Neutral rating and a price target of $22.00.
For an analyst ratings summary and ratings history on Cartesian Therapeutics click here. For more ratings news on Cartesian Therapeutics click here.
Shares of Cartesian Therapeutics closed at $18.83 yesterday.
You May Also Be Interested In
- Axis Capital Limited Assumes Jubilant Foodworks Ltd (JUBI:IN) at Reduce (3)
- BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform
- HSBC Upgrades Sembcorp Industries (SCI:SP) to Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
